fructosamine has been researched along with metformin in 23 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 7 (30.43) | 18.2507 |
| 2000's | 9 (39.13) | 29.6817 |
| 2010's | 6 (26.09) | 24.3611 |
| 2020's | 1 (4.35) | 2.80 |
| Authors | Studies |
|---|---|
| Chow, CC; Cockram, CS; Sorensen, JP; Tsang, LW | 1 |
| Handberg, A; Høyer, PE; Kayser, L; Micheelsen, J; Vinten, J | 1 |
| Handberg, A; Hansen, HP; Høyer, PE; Kayser, L; Vinten, J; Voldstedlund, M | 1 |
| Chan, JC; Cockram, CS; Critchley, JA; Tomlinson, B; Walden, RJ | 1 |
| Nagi, DK; Yudkin, JS | 1 |
| Golay, A; Lehmann, T; Morel, Y; Pasik, C; Perneger, T; Reaven, GM; Vadas, L | 1 |
| Kruszynska, YT; Mulford, MI; Olefsky, JM; Yu, JG | 1 |
| Djordjević, PB; Jevtović, T; Kocić, G; Kocić, R; Mikić, D; Pavlović, D; Radenković, S; Stojanović, M | 1 |
| Allavoine, T; Howlett, H; Lehert, P; Marre, M | 1 |
| Bell-Farrow, AD; Cefalu, WT; Edwards, IJ; Terry, JG | 1 |
| Baron, AD; Bicsak, TA; Fineman, MS; Gaines, E; Kim, D; Shen, LZ; Taylor, K; Varns, A | 1 |
| Bruce, S; Dandona, P; Donovan, DS; Garber, AJ; Park, JS | 1 |
| Baillet, L; Gin, H; Rigalleau, V; Roudaut, MF; Vergnot, V | 1 |
| Berner, B; Chiang, YK; Cramer, M; Fonseca, V; Lewin, A; Schwartz, S | 1 |
| Cui, F; Lian, B; Zhang, Z | 1 |
| Figenschau, Y; Jorde, R | 1 |
| Chanouan, R; Chotchaisuwat, P; Fuangchan, A; Haines, ST; Ingkaninan, K; Plianbangchang, P; Seubnukarn, T; Sirigulsatien, V; Sonthisombat, P | 1 |
| Erejuwa, OO; Gurtu, S; Salleh, MS; Sirajudeen, KN; Sulaiman, SA; Wahab, MS | 1 |
| Ciudin, A; Mesa, J; Simó, R; Valladares, S; Zafon, C | 1 |
| Bertrand, JH; Catargi, B; Douard, H; Feige, JM; Fischbach, M; Iliou, MC; Patois-Vergès, B; Simoneau-Robin, I; Vergès, B | 1 |
| Baker, EH; Hitchings, AW; Jones, PW; Lai, D | 1 |
| Szwergold, B | 1 |
| Bassols, J; Carreras-Badosa, G; De Zegher, F; Ibáñez, L; Lizárraga-Mollinedo, E; López-Bermejo, A; Mas-Parés, B; Platero-Gutierrez, E; Prats-Puig, A; Reixach, J; Tibau, J; Xargay-Torrent, S | 1 |
15 trial(s) available for fructosamine and metformin
| Article | Year |
|---|---|
Comparison of insulin with or without continuation of oral hypoglycemic agents in the treatment of secondary failure in NIDDM patients.
Topics: Analysis of Variance; Biomarkers; Blood Glucose; Body Mass Index; C-Peptide; Cholesterol; Cholesterol, HDL; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Female; Fructosamine; Gliclazide; Glipizide; Glyburide; Glycated Hemoglobin; Hexosamines; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Treatment Failure; Triglycerides | 1995 |
Metabolic and hemodynamic effects of metformin and glibenclamide in normotensive NIDDM patients.
Topics: Biomarkers; Blood Glucose; Blood Pressure; Cardiac Output; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Diabetes Mellitus, Type 2; Female; Fructosamine; Glyburide; Glycated Hemoglobin; Heart Rate; Hemodynamics; Hexosamines; Humans; Male; Metformin; Middle Aged; Posture; Triglycerides; Vascular Resistance | 1993 |
Effects of metformin on insulin resistance, risk factors for cardiovascular disease, and plasminogen activator inhibitor in NIDDM subjects. A study of two ethnic groups.
Topics: Albuminuria; Asia; Biomarkers; Blood Glucose; C-Peptide; Cardiovascular Diseases; Cholesterol; Diabetes Mellitus, Type 2; Diabetic Angiopathies; Double-Blind Method; Ethnicity; Fructosamine; Hexosamines; Humans; Insulin; Insulin Resistance; Islets of Langerhans; Metabolic Clearance Rate; Metformin; Plasminogen Activator Inhibitor 1; Platelet Aggregation; Risk Factors; Triglycerides; United Kingdom; White People | 1993 |
Metformin treatment leads to an increase in basal, but not insulin-stimulated, glucose disposal in obese patients with impaired glucose tolerance.
Topics: Blood Glucose; C-Peptide; Double-Blind Method; Female; Fructosamine; Glucose Intolerance; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Insulin Resistance; Insulin Secretion; Male; Metformin; Obesity; Placebos | 1999 |
A comparison of troglitazone and metformin on insulin requirements in euglycemic intensively insulin-treated type 2 diabetic patients.
Topics: Blood Glucose; Body Weight; C-Peptide; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Chromans; Circadian Rhythm; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Drug Therapy, Combination; Fatty Acids, Nonesterified; Female; Fructosamine; Humans; Hypoglycemic Agents; Insulin; Insulin Infusion Systems; Male; Metformin; Middle Aged; Thiazoles; Thiazolidinediones; Triglycerides; Troglitazone | 1999 |
Improved glycaemic control with metformin-glibenclamide combined tablet therapy (Glucovance) in Type 2 diabetic patients inadequately controlled on metformin.
Topics: Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Drug Combinations; Female; Fructosamine; Gastrointestinal Diseases; Glyburide; Glycated Hemoglobin; Humans; Hyperglycemia; Hypoglycemia; Hypoglycemic Agents; Lipids; Male; Metformin; Middle Aged; Tablets; Treatment Outcome | 2002 |
Improved glucose control decreases the interaction of plasma low-density lipoproteins with arterial proteoglycans.
Topics: Adult; Aged; Analysis of Variance; Blood Glucose; Diabetes Mellitus, Type 2; Female; Fructosamine; Glipizide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Lipids; Lipoproteins, LDL; Male; Metformin; Middle Aged; Proteoglycans | 2002 |
Effect on glycemic control of exenatide (synthetic exendin-4) additive to existing metformin and/or sulfonylurea treatment in patients with type 2 diabetes.
Topics: Blood Glucose; Blood Pressure; Body Weight; Diabetes Mellitus, Type 2; Drug Therapy, Combination; Exenatide; Female; Fructosamine; Glycated Hemoglobin; Heart Rate; Humans; Hypoglycemic Agents; Islets of Langerhans; Lipids; Male; Metformin; Middle Aged; Peptides; Sulfonylurea Compounds; Treatment Outcome; Venoms | 2003 |
Efficacy of glyburide/metformin tablets compared with initial monotherapy in type 2 diabetes.
Topics: Adult; Aged; Blood Glucose; Body Weight; Diabetes Mellitus, Type 2; Double-Blind Method; Drug Combinations; Female; Fructosamine; Glyburide; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin; Male; Metformin; Middle Aged; Postprandial Period | 2003 |
Effect of metformin on fibrinolytic parameters in insulin-treated, type 2 diabetic patients.
Topics: Aged; Analysis of Variance; Blood Glucose; Cholesterol, LDL; Diabetes Mellitus, Type 2; Fibrinogen; Fibrinolysis; Fructosamine; Humans; Hypoglycemic Agents; Insulin; Metformin; Middle Aged; Plasminogen Activator Inhibitor 1 | 2003 |
Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes.
Topics: Adolescent; Adult; Aged; Blood Glucose; Delayed-Action Preparations; Diabetes Mellitus, Type 2; Dose-Response Relationship, Drug; Double-Blind Method; Female; Fructosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged | 2006 |
Supplementation with cholecalciferol does not improve glycaemic control in diabetic subjects with normal serum 25-hydroxyvitamin D levels.
Topics: Adult; Aged; Blood Glucose; C-Peptide; Calcifediol; Calcium; Cholecalciferol; Diabetes Mellitus, Type 2; Dietary Supplements; Female; Fructosamine; Glycated Hemoglobin; Humans; Insulin; Insulin, Long-Acting; Male; Metformin; Middle Aged; Young Adult | 2009 |
Hypoglycemic effect of bitter melon compared with metformin in newly diagnosed type 2 diabetes patients.
Topics: Adult; Asia; Diabetes Mellitus, Type 2; Double-Blind Method; Female; Fructosamine; Fruit; Humans; Hypoglycemic Agents; Male; Medicine, Traditional; Metformin; Middle Aged; Momordica; Phytotherapy; Plant Preparations | 2011 |
Influence of glycemic control on gain in VO2 peak, in patients with type 2 diabetes enrolled in cardiac rehabilitation after an acute coronary syndrome. The prospective DARE study.
Topics: Acute Coronary Syndrome; Aged; Blood Glucose; Diabetes Mellitus, Type 2; Exercise Therapy; Female; Fructosamine; Glycated Hemoglobin; Humans; Hypoglycemic Agents; Insulin Aspart; Insulin Glargine; Male; Metformin; Middle Aged; Oxygen Consumption; Pulmonary Gas Exchange; Pulmonary Ventilation; Treatment Outcome | 2015 |
Metformin in severe exacerbations of chronic obstructive pulmonary disease: a randomised controlled trial.
Topics: Adult; Aged; Blood Glucose; C-Reactive Protein; Disease Progression; Double-Blind Method; Female; Fructosamine; Humans; Hypoglycemic Agents; Male; Metformin; Middle Aged; Pulmonary Disease, Chronic Obstructive; Treatment Outcome | 2016 |
8 other study(ies) available for fructosamine and metformin
| Article | Year |
|---|---|
Elevated GLUT 1 level in crude muscle membranes from diabetic Zucker rats despite a normal GLUT 1 level in perineurial sheaths.
Topics: Animals; Blood Glucose; Cell Membrane; Diabetes Mellitus; Electrophoresis, Polyacrylamide Gel; Femoral Nerve; Fructosamine; Glucose Transporter Type 1; Hexosamines; Insulin; Male; Metformin; Molecular Weight; Monosaccharide Transport Proteins; Muscles; Myelin Sheath; Obesity; Rats; Rats, Zucker; Reference Values | 1994 |
Metformin ameliorates diabetes but does not normalize the decreased GLUT 4 content in skeletal muscle of obese (fa/fa) Zucker rats.
Topics: Animals; Biomarkers; Blood Glucose; Cell Membrane; Diabetes Mellitus; Diabetes Mellitus, Type 1; Fructosamine; Hexosamines; Immunoblotting; Male; Metformin; Monosaccharide Transport Proteins; Muscles; Obesity; Rats; Rats, Zucker | 1993 |
Effect of four-week metformin treatment on plasma and erythrocyte antioxidative defense enzymes in newly diagnosed obese patients with type 2 diabetes.
Topics: Blood Glucose; C-Peptide; Catalase; Diabetes Mellitus; Diabetes Mellitus, Type 2; Erythrocytes; Fructosamine; Glutathione; Glutathione Peroxidase; Humans; Hydrogen Peroxide; Hypoglycemic Agents; In Vitro Techniques; Lipid Peroxidation; Metformin; Middle Aged; Obesity; Oxidative Stress; Reference Values; Superoxide Dismutase | 2000 |
Effect of FeSO4 treatment on glucose metabolism in diabetic rats.
Topics: Animals; Blood Glucose; Body Weight; Citric Acid Cycle; Diabetes Mellitus, Experimental; Electron Transport; Ferrous Compounds; Fructosamine; Glycolysis; Male; Metformin; Rats; Rats, Sprague-Dawley | 2008 |
Glibenclamide or metformin combined with honey improves glycemic control in streptozotocin-induced diabetic rats.
Topics: Animals; Bilirubin; Blood Glucose; Body Weight; Creatinine; Diabetes Mellitus, Experimental; Eating; Fructosamine; Glyburide; Honey; Hypoglycemic Agents; Insulin; Male; Metformin; Rats; Rats, Sprague-Dawley | 2011 |
Variables involved in the discordance between HbA1c and fructosamine: the glycation gap revisited.
Topics: Analysis of Variance; Creatinine; Diabetes Mellitus, Type 2; Fructosamine; Glycated Hemoglobin; Glycosylation; Humans; Hypoglycemic Agents; Logistic Models; Metformin; Spain | 2013 |
Reactions between methylglyoxal and its scavengers in-vivo appear to be catalyzed enzymatically.
Topics: Aldehydes; Carbon; Cardiovascular Agents; Catalysis; Diabetes Complications; Dihydroxyacetone; Fructosamine; Fructose-Bisphosphate Aldolase; Glutathione; Humans; Hydrogen-Ion Concentration; Kinetics; Metformin; Models, Biological; Pentoses; Phenotype; Polyphenols; Pyruvaldehyde | 2017 |
Metabolic programming in the offspring after gestational overfeeding in the mother: toward neonatal rescuing with metformin in a swine model.
Topics: Adipose Tissue; Animals; Female; Fructosamine; Humans; Metformin; Mothers; Overnutrition; Swine; Weight Gain | 2022 |